Uterine cervical cancer screening in Japan: Today and future

Journal of UOEH

Volumn 31, Issue 2, 2009, Pages 181-193

  Matsuura, Yusuke ^a   Kawagoe, Toshinori ^a   Toki, Naoyuki ^a   Hachisuga, Toru ^a   Kashimura, Masamichi ^b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Cancer screening; Cytology; Human papillomavirus (HPV); Uterine cervical cancer

Indexed keywords

ADULT; ARTICLE; CYTODIAGNOSIS; FEMALE; HUMAN; JAPAN; STANDARD; UTERINE CERVIX TUMOR; VIRUS INFECTION;

ADULT; CYTODIAGNOSIS; FEMALE; HUMANS; JAPAN; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 68049106039     PISSN: 0387821X     EISSN: None     Source Type: Journal    
DOI: 10.7888/juoeh.31.181     Document Type: Article

References (42)

1. Japanese Source (2006): Japanese Source 18 insert Japanese Source http://www.mhlw.go.jp/toukei/saikin/hw/jnkou/kakutei06/index.html
2. UNFPA (2009): population issues, united nations population fund UNFPA, New York http://www.unfpa.org/public/
3. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W & Sobue T; Japan Cancer Surveillance Research Group (2008): Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population-based cancer registries. Jpn J Clin Oncol 38: 641-648
4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ & Mufioz N (1999): Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19
5. Japanese Source (2001): Japanese Source 83: 3211-3215
6. Japanese Source (2008): Japanese Source 2006 Japanese Source 60: 1001-1026
7. Dürst M, Gissmann L, Ikenberg H & zur Hausen H (1983): A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 80: 3812-3815
8. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, van der Linden HC, Voorhorst FJ, Kenemans P & Meijer CJ (1999): Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: a prospective study. Lancet 354: 20-25
9. Matsuura Y, Kawagoe T, Toki N, Sugihara K & Kashimura M (1998): Low grade cervical intraepi-thelial neoplasia associated with human papillomavirus infection. Long-term follow-up. Acta Cytol 42: 625-630
10. Japanese Source (1998): Japanese Source pp107-171
11. Morrison BJ (1994): Screening for cervical cancer. In: Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa pp 870-881
12. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ & Cohen C; American Cancer Society (2002): American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 52: 342-362
13. Japanese Source (2004) Japanese Source0427001 Japanese Source http://www.mhlw.go.jp/shingi/2004/04/s0427-2.html
14. Sato S, Matsunaga G, Konno R & Yajima A(l998): Mass screening for cancer of uterine cervix in Miyagi prefecture in Japan. Effects and problems. Acta Cytol 42: 299-304
15. Japanese Source (2007) Japanese Source 94: 120-131
16. National Cancer Institute (2007): Cervical Cancer Mortality Rates. National Cancer Institute, Be-thesda http://appliedresearch.cancer.gov/icsn/cervical/mortality.html
17. Pairwuti S (1991): False-negative Papanicolaou smears from women with cancerous and precancerous lesions of the uterine cervix. Acta Cytol 35: 40-46
18. Gay JD, Donaldson LD & Goellner JR(1985): False-negative results in cervical cytologic studies. Acta Cytol 29: 1043-1046
19. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD & Matchar DB (2000): Ac curacy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med 132: 810-819
20. Japanese Source (1994) Japanese Source 5 Japanese Source http://www.jpha.or.jp/.
21. U.S. Preventive Services Task Force (1996): Guide to clinical preventive services. 2nd ed, Wil liams & Wilkins, Baltimore http://www.ahrg.gov/clinic/uspstfix.htm.
22. Rubio CA(1981): False negatives in cervical cytology: can they be avoided? Acta Cytol 25: 199-202
23. Bosch MM, Rietveld-Scheffers PE & Boon ME (1992): Characteristics of false-negative smears tested in the normal screening situation. Acta Cytol 36: 711-716
24. Papanicolaou GN & Traut HF (1943): Diagnosis of uterine cancer by the vaginal smear. The Commonwealth Fund. Harvard University Press, New York 46pp
25. Japanese Source (1997) Japanese Source http://www.jaog.or.jp/
26. Japanese Source (1993): Japanese Source 15: 37-43
27. Solomon D, Davey D, Kurman R et al (2002): Forum group members; Bethesda 2001 workshop. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 287: 2114 -2119
28. Kirschner B,Simonsen K & Junge j(2006): Comparison of conventional Papanicolaou smear and SurePath liquid-based cytology in the Copenhagen population screening programme for cervical can cer. Cytopathology 17: 187-194
29. Sung HY, Kearney KA, Miller M,Kinney W, Sawaya GF & Hiatt RA(2000): Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer 88: 2283-2289
30. Japanese Source (2008) Japanese Source 47: 7-13
31. Japanese Source (2008)Japanese Source 57: 1351-1356
32. Japanese Source (2000):Japanese Source 49: 501-508
33. Missaoui N, Hmissa S, Frappart L, Trabelsi A, Ben Abdelkader A, Traore C, Mokni M, Yaacoubi MT & Korbi S (2006): pl6INK4A overexpression and HPV infection in uterine cervix adenocarcinoma. Virchows Arch 448: 597-603
34. Mitchell HS & Giles GG (1996): Cancer diagnosis after a report of negative cervical cytology. Med J Aust 164: 270-273
35. Coleman DV & Poznansky JJ (2006): Review of cervical smears from 76 women with invasive cervical cancer: cytological findings and medicolegal implications. Cytopathology 17: 127-136
36. Japanese Source (1999): Japanese Source 79: 707-712
37. Japanese Source (1984): Japanese Source 36: 2598-2604
38. Japanese Source (1990): Japanese Source 57: 2443-2447
39. Japanese Source (2004): Japanese Source 43: 1-6
40. Sawaya GF, Me Connell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, Lee NC, Gildengorin G, Myers ER & Washington AE(2003): Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med 349: 1501-1509.
41. Schiffman M, Solomon D et al (2004): Interim guidance for the use of human papillo-mavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 103: 304-309
42. Kjaer S, HjSgdall E, Frederiksen K, Munk C, van den Brule A, Svare E, Meijer C, Lorincz A & Iftner T (2006): The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cy-tologically normal women over a 10-year period. Cancer Res 66: 10630 -10636